LoginSubscribe DatabaseScreen Shots


Bioxel Pharma Ceases Operations

TechFinance.ca News
Monday March 30, 2009

Bioxel Pharma Inc. (TSX-V: BIP) announced today that with the approval of the court pursuant to proceedings under t...



[ ... to read the whole article, subscription is required ... ]



... ... claims. Shareholders will not receive any consideration for their shares. Bioxel Pharma said the monitor will make...


To read this or any other article, or trial test our database, please try our 7 days or 1 month subscription, Click Here for Details.





Company Deals and People
Date
Title
Type
2008/4/2
Bioxel Pharma Closes Private Placement
Financing
2007/6/27
Bioxel Pharma Announces Short Form Prospectus Offering
Financing
2006/2/16
Bioxel Pharma Closes $4.7 Million Private Placement
Financing
2005/1/14
Pascal Delmas, President & CEO
Management
2004/9/16
Bioxel Pharma Completes Private Placement
Financing
2003/6/5
Jacques Jean Boisvert
Director
2003/6/5
Danny Gagné
Director
2003/3/7
Bioxel Pharma Closes $9.5 Million Public Offering
Financing
2002/7/9
Bioxel Completes $3 Million Financing
Financing
2002/1/11
Bioxel Pharma Closes Private Placement
Financing
2001/8/13
Bioxel Pharma Lists on CDNX
RTO, QT
2001/4/20
Bioxel Pharma Completes $2.2 Million Private Placement
Financing

 
Bioxel Pharma Inc.
TSX-V: BIP
» To this firm page « (subscriber only)

3075 Chemin des Quatre-Bourgeois, Suite 440
Sainte-Foy, QC   G1W 4Y5
Tel:  (418) 654-9666
Fax:  (418) 654-9655
http://www.bioxelpharma.com

Sector - Biotechnology, Biopharmaceuticals

Business Description
Bioxel Pharma is a biopharmaceutical company focused on the manufacture and distribution of taxane pharmaceutical ingredients including paclitaxel, docetaxel, 9-DHB and 10-DAB.


Company News
Bioxel Pharma Ceases Operations 2009/3/30
Dr. Pascal Delmas Appointed President & CEO of Bioxel Pharma Inc. 2005/1/14